Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Industry

University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre

Sreepriya Prasannan
Sreepriya Prasannan
Speed:
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre

The University of Galway has been selected to lead the new €64.5 million Rinn Medical Devices Centre, a cornerstone of a landmark €460 million national investment in seven new national research centres established under Research Ireland. The announcement, which marks one of the largest single investments in Irish research and innovation history, consolidates Galway's reputation as a premier global MedTech and life sciences hub.

The funding announcement was made by the Minister for Further and Higher Education, Research, Innovation and Science, James Lawless T.D., highlighting the Irish government's commitment to building a coordinated, world-class national research network. The new Rinn Centres are scheduled to commence operations in July 2026 and will run for an initial period of eight years, supported by more than 200 industry partners (including 100 multinational corporations and nearly 100 SMEs).

Galway Leads the Charge in MedTech Innovation

The €64.5 million Rinn Medical Devices Centre will be directed by Professor Abhay Pandit and will focus on developing next-generation medical device innovations designed to address chronic health conditions, support healthy ageing, and improve patient quality of life. The new centre builds directly on over a decade of pioneering research, clinical trials, and commercial breakthroughs achieved by the CÚRAM Research Ireland Centre for Medical Devices, which was established in 2015.

Professor Abhay Pandit, Director of Rinn Medical Devices, emphasized the translation-focused and patient-centric design of the new centre:

"Anchored within a dynamic ecosystem of researchers, clinicians, industry partners and innovators, Rinn Medical Devices will accelerate the translation of research into real-world health solutions and drive innovation in medtech from Galway to patients worldwide. At every step, patient voices, experiences, and priorities shape what we do and how we do it, ensuring that the devices we develop are not just scientifically sound, but genuinely meaningful to the people they're designed to help."

Partnering Across All Seven National Centres

The University of Galway's selection is a major academic milestone: the university will partner on all seven new national Rinn research centres - making it one of only three higher education institutions in Ireland to achieve this comprehensive footprint. Across the 17 research-performing organisations in the country, Galway is one of only two to partner across the entire network.

Aengus Parsons, Interim Vice-President for Research and Innovation at the University of Galway, stated:

"Out of 17 research performing organisations, the University of Galway is one of only two to partner across all seven Rinn centres. This uniquely positions us to support interdisciplinary collaboration and maximise the impact of this national investment."

Professor David Burn, President of the University of Galway, welcomed the scale of the investment:

"Government investment of this scale in this new initiative recognises the vital role of research and innovation in addressing pressing societal and economic priorities for Ireland and globally. Our leadership of Rinn Medical Devices, and partnering across all seven research centres, demonstrates the depth of research excellence in University of Galway, and reflects the scale of our success in the fields of medical devices and new healthcare therapies over the last decade as well as our excellence in energy, AI and quantum science."

Galway's Leadership in the National Rinn Network

In addition to directing the Medical Devices Centre, University of Galway academics will hold prominent leadership and deputy director roles across the Rinn network:

  • Rinn Advanced Therapies: Focused on developing and manufacturing personalized cellular immune therapeutics for cancer and serious diseases. The Galway Deputy Director is Professor Aideen Ryan (School of Medicine).
  • Rinn Artificial Intelligence: A national hub to advance data science and AI research. The Galway lead is Professor Edward Curry (Data Science Institute and School of Computer Science).
  • Rinn Energy: Driving energy system decarbonization. The Galway leads are Professor Rory Monaghan (Deputy Director, School of Engineering) and Professor Frances Fahy (Ryan Institute).
  • Rinn Quantum: Establishing Ireland as a global leader in quantum science. The Galway Deputy Director is Professor J-C Desplat (Irish Centre for High-End Computing - ICHEC).
  • Rinn Pharma and Biopharma & Rinn Semiconductors: Galway researchers will act as core academic partners, helping drive therapeutic manufacturing and microchip research.

The Rinn Centres are designed to support 577 researchers and 800 PhD candidates across Ireland, creating a robust talent pipeline for the country's high-tech and biopharma industries. By integrating academic excellence with direct clinical applications and industrial collaboration, the network aims to secure Ireland's competitive edge in the global knowledge economy for the next decade.

Frequently Asked Questions

What is the focus of the Galway Rinn Medical Devices Centre?

The centre focuses on researching and developing next-generation medical devices, smart implants, and minimally invasive diagnostic technologies.

Who funds the €64.5 million medical device centre?

It is co-funded by Research Ireland (the merged SFI and IRC body), academic institutions, and leading multinational MedTech corporate partners.

How does Galway's MedTech cluster support this centre?

Galway is a top-five global MedTech hub, providing the centre with access to advanced manufacturing partners, clinical trial sites, and specialized engineering talent.

Frequently Asked Questions

What is the focus of the Galway Rinn Medical Devices Centre?

The centre focuses on researching and developing next-generation medical devices, smart implants, and minimally invasive diagnostic technologies.

Who funds the €64.5 million medical device centre?

It is co-funded by Research Ireland (the merged SFI and IRC body), academic institutions, and leading multinational MedTech corporate partners.

How does Galway's MedTech cluster support this centre?

Galway is a top-five global MedTech hub, providing the centre with access to advanced manufacturing partners, clinical trial sites, and specialized engineering talent.

Reviewed for editorial accuracy by Sreepriya Prasannan, Founder & Editor MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany
Our standards
Related from our data
Medical Air — Oxygen · Irish Medicines Database Medical Carbon Dioxide — Carbon dioxide · Irish Medicines Database Medical Nitrous Oxide — Nitrous oxide · Irish Medicines Database
Most-trialled drugs in our registers
Browse all trial registers →

Get the Friday brief

One email every Friday: the week's Irish pharma news, new EMA and FDA approvals, EU and US medicine shortages and how many trials are recruiting in Ireland, built from public registers.

Free. Unsubscribe from any email with one click. See our privacy policy.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Industry

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment